These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 16607754

  • 1. Molecular mechanisms in hormone-resistant prostate cancer.
    Roznovanu SL, Amălinci C, Rădulescu D.
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(3):577-83. PubMed ID: 16607754
    [Abstract] [Full Text] [Related]

  • 2. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
    Tørring N, Jørgensen PE, Sørensen BS, Nexø E.
    Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
    [Abstract] [Full Text] [Related]

  • 3. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
    Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H.
    Cancer Res; 1994 Oct 15; 54(20):5474-8. PubMed ID: 7522959
    [Abstract] [Full Text] [Related]

  • 4. In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR).
    Nickerson T, Chang F, Lorimer D, Smeekens SP, Sawyers CL, Pollak M.
    Cancer Res; 2001 Aug 15; 61(16):6276-80. PubMed ID: 11507082
    [Abstract] [Full Text] [Related]

  • 5. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ, Mohan S, Cohen P, Foster BA, Greenberg NM.
    Cancer Res; 1999 May 01; 59(9):2203-9. PubMed ID: 10232609
    [Abstract] [Full Text] [Related]

  • 6. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL, McBride WH, Sun J, Patel B, Tsui KH, Paik SH, Gitlitz B, Caliliw R, van Ophoven A, Wu L, deKernion J, Belldegrun A.
    Cancer J; 2000 May 01; 6(4):220-33. PubMed ID: 11038142
    [Abstract] [Full Text] [Related]

  • 7. Overcoming bcl-2- and p53-mediated resistance in prostate cancer.
    DiPaola RS, Aisner J.
    Semin Oncol; 1999 Feb 01; 26(1 Suppl 2):112-6. PubMed ID: 10190792
    [Abstract] [Full Text] [Related]

  • 8. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
    Seth D, Shaw K, Jazayeri J, Leedman PJ.
    Br J Cancer; 1999 May 01; 80(5-6):657-69. PubMed ID: 10360641
    [Abstract] [Full Text] [Related]

  • 9. Androgen axis in prostate cancer.
    Culig Z, Bartsch G.
    J Cell Biochem; 2006 Oct 01; 99(2):373-81. PubMed ID: 16598769
    [Abstract] [Full Text] [Related]

  • 10. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.
    Prostate; 2008 Feb 15; 68(3):287-95. PubMed ID: 18163430
    [Abstract] [Full Text] [Related]

  • 11. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J, Sommer A.
    J Steroid Biochem Mol Biol; 2005 Feb 15; 93(2-5):191-200. PubMed ID: 15860262
    [Abstract] [Full Text] [Related]

  • 12. Molecular regulation of androgen action in prostate cancer.
    Dehm SM, Tindall DJ.
    J Cell Biochem; 2006 Oct 01; 99(2):333-44. PubMed ID: 16518832
    [Abstract] [Full Text] [Related]

  • 13. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
    Brass AL, Barnard J, Patai BL, Salvi D, Rukstalis DB.
    Cancer Res; 1995 Jul 15; 55(14):3197-203. PubMed ID: 7606741
    [Abstract] [Full Text] [Related]

  • 14. Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP.
    Henttu P, Vihko P.
    Cancer Res; 1993 Mar 01; 53(5):1051-8. PubMed ID: 7679946
    [Abstract] [Full Text] [Related]

  • 15. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.
    Shi Y, Chatterjee SJ, Brands FH, Shi SR, Pootrakul L, Taylor CR, Datar R, Cote RJ.
    BJU Int; 2006 Jan 01; 97(1):170-8. PubMed ID: 16336351
    [Abstract] [Full Text] [Related]

  • 16. Androgen-regulated gene expression in prostate cancer.
    Trapman J, Cleutjens KB.
    Semin Cancer Biol; 1997 Feb 01; 8(1):29-36. PubMed ID: 9299579
    [Abstract] [Full Text] [Related]

  • 17. Amplification and co-regulators of androgen receptor gene in prostate cancer.
    Golias Ch, Iliadis I, Peschos D, Charalabopoulos K.
    Exp Oncol; 2009 Mar 01; 31(1):3-8. PubMed ID: 19300409
    [Abstract] [Full Text] [Related]

  • 18. The importance of steroid hormones in prostate cancer.
    Wilding G.
    Cancer Surv; 1992 Mar 01; 14():113-30. PubMed ID: 1423327
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
    Wu JD, Haugk K, Woodke L, Nelson P, Coleman I, Plymate SR.
    J Cell Biochem; 2006 Oct 01; 99(2):392-401. PubMed ID: 16639715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.